Policy and Legislation
Dr. Donald Rucker, chief of the Office of the National Coordinator for Healthcare Information Technology, discusses the rollout of the 21st Century Cures Act and the opportunities it provides for health tech startups.
While optional Medicare for All is popular among voters, many are wary of breaking from the traditional private insurance system.
In total, Affordable Care Act insurers in a class action lawsuit will receive over $1.5 billion in damages from 2017 and 2018.
President Trump, who was supposedly trying to sabotage the ACA, has been better at running it than President Obama, who wrote the law, says HHS Secretary Alex Azar.
Prince Court Medical Centre's Dr. Kuljit Singh discusses efforts to self-regulate drug price control with Malaysia's unique healthcare payment landscape.
Germany must focus on evolution over revolution in its efforts to advance healthcare digitally, but true value can only be realized with close stakeholder collaboration, says Armin Scheuer, HIMSS VP of international business development.
The FDA is also approving greater numbers of complex generic drugs, which are more difficult to replicate and traditionally lack competition.
Different states have different methods for identifying 340B drugs billed to programs, findings showed.
A limited public option that largely preserves employment-based insurance would have only a small impact, while Medicare for All is an existential threat, Moody's says.
Only 18% of the executives surveyed at U.S. healthcare companies say they are "very familiar" with new regulations.